Introduction: Metabolomics is an emerging approach providing new insights into the metabolic changes and underlying mechanisms involved in the pathogenesis of neurological disorders. Areas covered: Here, the authors present an overview of the current knowledge of metabolic profiling (metabolomics) to provide critical insight on the role of biochemical markers and metabolic alterations in neurological diseases. Expert opinion: Elucidation of characteristic metabolic alterations in neurological disorders is crucial for a better understanding of their pathogenesis, and for identifying potential biomarkers and drug targets. Nevertheless, discrepancies in diagnostic criteria, sample handling protocols, and analytical methods still affect the generalizability of current study results.

Bonomo, R., Cavaletti, G., Skene, D. (2020). Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting. EXPERT REVIEW OF NEUROTHERAPEUTICS, 20(7), 725-738 [10.1080/14737175.2020.1782746].

Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting

Bonomo, R
Primo
;
Cavaletti, G
;
2020

Abstract

Introduction: Metabolomics is an emerging approach providing new insights into the metabolic changes and underlying mechanisms involved in the pathogenesis of neurological disorders. Areas covered: Here, the authors present an overview of the current knowledge of metabolic profiling (metabolomics) to provide critical insight on the role of biochemical markers and metabolic alterations in neurological diseases. Expert opinion: Elucidation of characteristic metabolic alterations in neurological disorders is crucial for a better understanding of their pathogenesis, and for identifying potential biomarkers and drug targets. Nevertheless, discrepancies in diagnostic criteria, sample handling protocols, and analytical methods still affect the generalizability of current study results.
Articolo in rivista - Review Essay
biochemical markers, drug targets, metabolites, Metabolomics, neurology
English
2020
20
7
725
738
reserved
Bonomo, R., Cavaletti, G., Skene, D. (2020). Metabolomics markers in Neurology: current knowledge and future perspectives for therapeutic targeting. EXPERT REVIEW OF NEUROTHERAPEUTICS, 20(7), 725-738 [10.1080/14737175.2020.1782746].
File in questo prodotto:
File Dimensione Formato  
ERN-2020--0055.R1_Proof_hi.pdf

Solo gestori archivio

Tipologia di allegato: Author’s Accepted Manuscript, AAM (Post-print)
Dimensione 382.12 kB
Formato Adobe PDF
382.12 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/279162
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
Social impact